# Janus Henderson Contrarian T (JSVAX)

> Source: Nexqual · https://nexqual.com/JSVAX · data as of 2026-10-24 00:08 UTC · cite as "Nexqual, Janus Henderson Contrarian T (JSVAX), nexqual.com/JSVAX" · informational, not investment advice.

**Price:** USD 29.29 (-0.44% on the day) · last close of Oct 23, 2026; US market closed, not a live price. Prev close 29.42 · day 29.29–29.29 · 52w 24.38–33.54 · market cap null · NAS

## Key facts
- Total return with dividends: 1Y +4.0% vs S&P 500 +13.4%; 5Y +31.6% vs S&P 500 +76.9%.

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-24) | 5Y (from 2021-10-25) |
|---|---|---|
| Total return | +4.0% | +31.6% |
| S&P 500 (SPY) | +13.4% | +76.9% |
| Per year | +4.1% | +5.7% |
| Volatility (annualized) | 23.0% | 21.1% |
| Max drawdown | -14.2% (Oct 2025→Mar 2026) | -30.1% (Nov 2021→Sep 2022) |

## Peers
JORNX (Janus Henderson Global Select F) USD 20.28 -0.00% · JAOSX (Janus Henderson Overseas Fund -) USD 61.77 -0.00% · JAGTX (Janus Henderson Global Technolo) USD 81.16 -0.00% · JAMRX (Janus Henderson Research Fund -) USD 90.58 -0.00% · JAGLX (Janus Henderson Global Life Sci) USD 89.14 +0.00%

## More
Full page: https://nexqual.com/JSVAX · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt